<Date>{12/03/2019}12.3.2019</Date>
<NoDocSe>B8‑0211/2019</NoDocSe>
PDF 125kWORD 48k

<TitreType>MOTION FOR A RESOLUTION</TitreType>

<TitreRecueil>pursuant to Rule 133 of the Rules of Procedure</TitreRecueil>


<Titre>on EU and Member State support at the 72nd WHO plenary meeting for a resolution entitled ‘Improving the transparency of markets for drugs, vaccines and other health-related technologies’</Titre>


<Depute>Piernicola Pedicini</Depute>


B8‑0211/2019

Motion for a European Parliament resolution on EU and Member State support at the 72nd WHO plenary meeting for a resolution entitled ‘Improving the transparency of markets for drugs, vaccines and other health-related technologies’

The European Parliament,

 having regard to Rule 133 of its Rules of Procedure,

A. whereas, in its resolution of 2 March 2017 on EU options for improving access to medicines[1], Parliament states that ensuring patient access to essential medicines is one of the core objectives of the EU and the WHO;

B. whereas the agenda of the WHO plenary meeting to be held in Geneva from 20 to 28 May 2019 lists, among the strategic priority matters to be discussed, item 11.7 ‘Addressing the global shortage of, and access to, medicines and vaccines’; whereas the Italian Government has tabled a comprehensive resolution on this topic;

C. whereas it is of the utmost importance to address properly the global shortage of, and access to, medicines and vaccines;

1. Calls on the EU and all Member States to agree on a common position supporting, at the upcoming 72nd WHO plenary meeting, the resolution entitled ‘Improving the transparency of markets for drugs, vaccines and other health-related technologies’, which sets out a number of measures designed to achieve this objective.

 

[1] OJ C 263, 25.7.2018, p. 4.

Last updated: 13 March 2019Legal notice